226 related articles for article (PubMed ID: 36032133)
61. [Expression Profile and Clinical Significance of Cytokines and Chemokines in Patients with Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis].
Gao Y; Zheng Y; Zhang WH; Li Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):268-273. PubMed ID: 36765510
[TBL] [Abstract][Full Text] [Related]
62. Flow Cytometric Analysis of T Cells in Hemophagocytic Lymphohistiocytosis.
Park MS; Yoo IY; Kim HJ; Kim SH; Kim SJ; Cho D
Ann Lab Med; 2019 Sep; 39(5):430-437. PubMed ID: 31037861
[TBL] [Abstract][Full Text] [Related]
63. [Research advance on Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis].
Wei Q; Wang Z
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1541-4. PubMed ID: 22169321
[TBL] [Abstract][Full Text] [Related]
64.
Wei A; Lu X; Ma H; Lian H; Yang X; Zhang L; Wang D; Chen S; Zhang Q; Li Z; Zhang R; Yang J; Wang T
Contrast Media Mol Imaging; 2022; 2022():4849081. PubMed ID: 35510179
[TBL] [Abstract][Full Text] [Related]
65. Ileal mass-like lesion induced by Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in a patient with aplastic anemia.
Min KW; Jung HY; Han HS; Hwang TS; Kim SY; Kim WS; Lim SD; Kim WY
APMIS; 2015 Jan; 123(1):81-6. PubMed ID: 25243347
[TBL] [Abstract][Full Text] [Related]
66. Nivolumab treatment of relapsed/refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults.
Liu P; Pan X; Chen C; Niu T; Shuai X; Wang J; Chen X; Liu J; Guo Y; Xie L; Wu Y; Liu Y; Liu T
Blood; 2020 Mar; 135(11):826-833. PubMed ID: 31914172
[TBL] [Abstract][Full Text] [Related]
67. Polymorphisms and haplotypes of IL2RA, IL10, IFNG, IRF5, and CCR2 are associated with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children.
Tang N; Huang J; Chen C; Wu X; Xu H; Chen G; Xue H
Pediatr Blood Cancer; 2021 Aug; 68(8):e29097. PubMed ID: 34031980
[TBL] [Abstract][Full Text] [Related]
68. Flow cytometric findings in hemophagocytic lymphohistiocytosis.
McCall CM; Mudali S; Arceci RJ; Small D; Fuller S; Gocke CD; Vuica-Ross M; Burns KH; Borowitz MJ; Duffield AS
Am J Clin Pathol; 2012 May; 137(5):786-94. PubMed ID: 22523218
[TBL] [Abstract][Full Text] [Related]
69. Successful treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-94 protocol.
Lee JS; Kang JH; Lee GK; Park HJ
J Korean Med Sci; 2005 Apr; 20(2):209-14. PubMed ID: 15831988
[TBL] [Abstract][Full Text] [Related]
70. Adult Lymphoma-Associated Hemophagocytic Lymphohistiocytosis: A Clinical Case Series in a Predominantly Hispanic Cohort.
Desai A; Saul EE; Chapman JR; Lekakis L; Pimentel A
J Med Cases; 2020 Aug; 11(8):256-261. PubMed ID: 34434407
[TBL] [Abstract][Full Text] [Related]
71. [The understanding of Epstein-Barr virus associated lymphoproliferative disorder].
Zhou XG; Zhang YL; Xie JL; Huang YH; Zheng YY; Li WS; Chen H; Liu F; Pan HX; Wei P; Wang Z; Hu YC; Yang KY; Xiao HL; Wu MJ; Yin WH; Mei KY; Chen G; Yan XC; Meng G; Xu G; Li J; Tian SF; Zhu J; Song YQ; Zhang WJ
Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):817-821. PubMed ID: 28056294
[TBL] [Abstract][Full Text] [Related]
72. PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Wang J; Wang Y; Wu L; Zhang J; Lai W; Wang Z
J Hematol Oncol; 2016 Sep; 9(1):84. PubMed ID: 27613189
[TBL] [Abstract][Full Text] [Related]
73. Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Imashuku S
Crit Rev Oncol Hematol; 2002 Dec; 44(3):259-72. PubMed ID: 12467966
[TBL] [Abstract][Full Text] [Related]
74. Clinicopathological findings of systemic Epstein-Barr virus-positive T-lymphoproliferative diseases in younger and older adults.
Wang Z; Kimura S; Iwasaki H; Takase K; Oshiro Y; Gamachi A; Makihara K; Ogata M; Daa T; Momosaki S; Takamatsu Y; Takeshita M
Diagn Pathol; 2021 Jun; 16(1):48. PubMed ID: 34088321
[TBL] [Abstract][Full Text] [Related]
75. Prevalence of Epstein-Barr Viral DNA among children at a single hospital in Suzhou, China.
Shi T; Huang L; Tian J
J Pediatr (Rio J); 2022; 98(2):142-146. PubMed ID: 34174213
[TBL] [Abstract][Full Text] [Related]
76. [Lung injury associated with severe Epstein-Barr virus (EBV) infection].
Cui Y; Zhang Y; Wang F; Zhu Y; Chen R; Xu L
Zhonghua Er Ke Za Zhi; 2015 Aug; 53(8):586-91. PubMed ID: 26717656
[TBL] [Abstract][Full Text] [Related]
77. Treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) in young adults: a report from the HLH study center.
Imashuku S; Kuriyama K; Sakai R; Nakao Y; Masuda S; Yasuda N; Kawano F; Yakushijin K; Miyagawa A; Nakao T; Teramura T; Tabata Y; Morimoto A; Hibi S
Med Pediatr Oncol; 2003 Aug; 41(2):103-9. PubMed ID: 12825212
[TBL] [Abstract][Full Text] [Related]
78. Treatment choice of immunotherapy or further chemotherapy for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Shiraishi A; Ohga S; Doi T; Ishimura M; Takimoto T; Takada H; Miyamoto T; Abe Y; Hara T
Pediatr Blood Cancer; 2012 Aug; 59(2):265-70. PubMed ID: 22183955
[TBL] [Abstract][Full Text] [Related]
79. Microbiological findings and treatment of EBV-associated hemophagocytic lymphohistiocytosis: a case report.
Przybylski M; Dzieciatkowski T; Zduńczyk D; Jedrzejczak WW; Luczak M
Arch Immunol Ther Exp (Warsz); 2010 Jun; 58(3):247-52. PubMed ID: 20383798
[TBL] [Abstract][Full Text] [Related]
80. Bone Marrow Histology in Hemophagocytic Lymphohistiocytosis.
Yu SC; Cheng CL; Huang HH; Lo HT; Liu YJ; Hsieh HP; Chao HL; Wang YH; Hsu CA; Teng SC
Arch Pathol Lab Med; 2023 Mar; 147(3):348-358. PubMed ID: 35738007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
